BED, or binge eating disorder, is a recognized mental health condition characterized by recurring episodes of eating unusually large amounts of food while feeling unable to stop. It affects roughly 1.2% of U.S. adults in any given year and is the most common eating disorder, more prevalent than anorexia or bulimia. Unlike bulimia, people with BED do not purge, fast, or use other compensatory behaviors after a binge.
What a Binge Episode Feels Like
A binge eating episode isn’t just overeating at a holiday dinner. It involves consuming a clearly excessive amount of food within a short window, typically around two hours, paired with a distinct sense of losing control. People describe feeling like they physically cannot stop eating or choose what or how much they consume, even when they want to.
During an episode, several patterns tend to appear together: eating much faster than usual, continuing to eat well past the point of physical comfort, eating large quantities without any real hunger, eating alone out of embarrassment, and feeling intense guilt, disgust, or depression afterward. A clinical diagnosis requires at least three of these features alongside the core loss of control. When researchers ask people with BED which features define their experience most, the top answers are extreme fullness, loss of control, and the low mood that follows.
The current diagnostic threshold is at least one binge episode per week for three months, along with significant emotional distress about the behavior. Many people experience episodes far more frequently than that minimum.
How BED Differs From Bulimia
The key distinction is what happens after a binge. In bulimia nervosa, binge episodes are followed by compensatory behaviors like self-induced vomiting, laxative use, excessive exercise, or severe calorie restriction. In BED, those behaviors are absent. The binge happens, the distress follows, but there is no purging.
The pathways into each disorder also differ. In most people with bulimia (about 89%), binge eating develops after a period of dieting and weight loss. For people with BED, the route is more variable. Some begin binge eating in childhood, others after emotional trauma, and the pattern doesn’t reliably follow a dieting history.
Who It Affects
BED occurs across all ages, body sizes, and backgrounds, though it is twice as common in women (1.6%) as in men (0.8%). The lifetime prevalence is about 2.8%, meaning nearly 3 in 100 people will experience it at some point. Eating disorders in general tend to emerge during adolescence and young adulthood, with onset often occurring around age 18, though BED can develop later in life as well.
It’s worth noting that BED is not synonymous with obesity. While many people with the disorder do carry excess weight, not all do, and most people with obesity do not have BED. The disorder is defined by the behavioral and emotional pattern, not by body size.
What Happens in the Brain
BED involves measurable differences in how the brain processes reward and impulse control. The brain’s reward circuitry, the same system involved in responses to pleasurable experiences, appears to be less responsive in people with BED. This under-responsiveness may drive a person to seek larger quantities of food to achieve the same level of satisfaction, creating a cycle where binge episodes further blunt the reward response over time.
Areas of the brain responsible for decision-making, impulse regulation, and processing taste signals also show structural and functional differences. These changes may exist before the disorder develops, acting as a vulnerability factor, and then worsen with repeated binge episodes. This helps explain why BED feels so involuntary to the people experiencing it. It is not a failure of willpower but a pattern reinforced by altered brain chemistry.
Physical Health Effects
BED produces medical complications across virtually every body system. Many of these overlap with conditions associated with obesity, including metabolic syndrome (a cluster of high blood pressure, elevated blood sugar, excess abdominal fat, and abnormal cholesterol levels), type 2 diabetes, and cardiovascular disease. But the disorder also carries gastrointestinal consequences from the binge episodes themselves, such as stomach pain, bloating, and acid reflux.
Over time, BED can significantly reduce both quality and length of life. The physical toll is compounded by the emotional burden, making early identification and treatment particularly important.
Mental Health Conditions That Overlap
BED rarely exists in isolation. Depression is the most commonly co-occurring condition, with prevalence rates among people with BED ranging from about 24% to 66% depending on the study. Anxiety disorders are similarly common, appearing in roughly 55% to 65% of people with BED across large population surveys.
ADHD shows a notable relationship with binge eating, with studies finding it in about 10% to 20% of people with BED. The connection likely involves shared difficulties with impulse control and reward processing. PTSD appears in roughly 10% to 32% of cases, and substance use disorders co-occur at rates between 9% and 68%, varying widely by study population. Experts who specialize in BED consistently identify depression and anxiety as the two conditions they encounter most frequently alongside it.
How BED Is Treated
Cognitive behavioral therapy (CBT) is the most established treatment. It typically runs 12 to 24 weeks of structured weekly sessions, either individually or in a group, focusing on identifying triggers for binge episodes, developing healthier coping strategies, and breaking the cycle of guilt and restriction that fuels further binges. In rigorous clinical trials, CBT produces remission (complete cessation of binge eating) in roughly 50% of patients, and those results hold up well over two to four years of follow-up.
Interpersonal therapy, which focuses on relationship patterns and social functioning rather than eating behavior directly, achieves similar remission rates. A newer approach called Integrative Cognitive-Affective Therapy, which targets the momentary emotional triggers of binge episodes, showed a 57% remission rate in a 17-week trial.
On the medication side, the FDA has approved one drug for moderate to severe BED in adults: lisdexamfetamine, originally developed for ADHD. It works by increasing certain brain chemicals involved in impulse control and reward. Because it belongs to the amphetamine class, it carries a risk of dependence, so it is typically reserved for cases where therapy alone hasn’t been sufficient. Generic versions are now available, improving access.
Treatment often works best when therapy and medication are combined, particularly for people with co-occurring depression or anxiety. Recovery is not always linear, but sustained remission is achievable for a meaningful percentage of people who engage in evidence-based treatment.